MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Iptacopan

CAS No. : 1644670-37-0

MCE 国际站：Iptacopan

产品活性：Iptacopan (LNP023) 是一种首创的，有效的，具有口服活性的高选择性的 factor B 抑制剂，IC₅₀ 值为 10 nM。Iptacopan 直接可逆且高亲和力结合 factor B，K_D为 7.9 nM。Iptacopan 可靶向 C3 肾小球病的根本病因。

研究领域：Immunology/Inflammation

作用靶点：Complement System

In Vitro: Iptacopan (LNP023) demonstrates potent inhibition of alternative complement pathway (AP)-induced membrane attack complex (MAC) formation in 50% human serum (IC₅₀ value of 130 nM).
Iptacopan (LNP023) exhibits excellent selectivity over other proteases affording IC₅₀ values of >30 µM across a panel of 41 human proteases, including the AP protein factor D (>100 µM).

In Vivo: Iptacopan (LNP023; 20-180 mg/kg; oral administration) prevents KRN (150 µL)-induced arthritis in mice and is effective upon prophylactic and therapeutic dosing in an experimental model of membranous nephropathy in rats.
LNP023 exhibits moderate half-lives (T_1/2; Wistar Han rats 3.4 h, beagle dogs 5.5 h) and C_max (Wistar Han rats 410 nM, beagle dogs 2200 nM) following oral administration (rat 30 and, dog 10 mg/kg).
Iptacopan exhibits terminal elimination half-lives (T_1/2; Wistar Han rats 7 h, beagle dogs 5.6 h) due to high plasma clearance (8, and 2 mL/min/kg respectively combined with large volumes of distribution (2.3, and 0.6 L/kg respectively) following intravenous administration (rat 1.0 and, dog 0.1 mg/kg).

相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Dexamethasone | Cyclosporin A | SB290157 trifluoroacetate | EG00229 | PMX-53 | PMX 205 Trifluoroacetate | Leukadherin-1 | EG01377 dihydrochloride | BCX 1470 methanesulfonate | W-54011 | Compstatin | TLQP-21 TFA | C3a (70⁻⁷7) TFA | FD-IN-1 | NDT 9513727 | Compstatin control peptide | POT-4

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。